The store will not work correctly when cookies are disabled.
US9428478, TG6-167-1
ID: ALA3986285
PubChem CID: 51178287
Max Phase: Preclinical
Molecular Formula: C19H22FN3O2
Molecular Weight: 343.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(N2CCN(C(=O)CNc3ccc(F)cc3)CC2)cc1
Standard InChI: InChI=1S/C19H22FN3O2/c1-25-18-8-6-17(7-9-18)22-10-12-23(13-11-22)19(24)14-21-16-4-2-15(20)3-5-16/h2-9,21H,10-14H2,1H3
Standard InChI Key: YHZUAOOBYJIYIH-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
2.5956 -2.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5987 1.5004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6012 3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9015 3.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1993 2.9963 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1969 1.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8967 0.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5018 3.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5058 4.9420 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.7993 2.9876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1017 3.7333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-10.3992 2.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.7021 3.7223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9973 2.9658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9898 1.4658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.0260 0.8606 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-11.6870 0.7224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3917 1.4789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
6 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
12 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
22 24 1 0
24 25 2 0
25 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 343.40 | Molecular Weight (Monoisotopic): 343.1696 | AlogP: 2.60 | #Rotatable Bonds: 5 |
Polar Surface Area: 44.81 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.01 | CX LogP: 2.29 | CX LogD: 2.29 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.91 | Np Likeness Score: -1.81 |
References
1. (2016) Piperazine derivatives, compositions, and uses related thereto, |